OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
2.385
-0.035 (-1.45%)
Mar 31, 2025, 10:53 AM EDT - Market open
OmniAb Employees
OmniAb had 114 employees as of December 31, 2024. The number of employees increased by 8 or 7.55% compared to the previous year.
Employees
114
Change (1Y)
8
Growth (1Y)
7.55%
Revenue / Employee
$231,500
Profits / Employee
-$544,149
Market Cap
291.29M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 114 | 8 | 7.55% |
| Dec 31, 2023 | 106 | 11 | 11.58% |
| Dec 31, 2022 | 95 | 21 | 28.38% |
| Dec 31, 2021 | 74 | 4 | 5.71% |
| Dec 31, 2020 | 70 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
OABI News
- 12 days ago - OmniAb, Inc. (OABI) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 12 days ago - OmniAb Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights - Business Wire
- 5 weeks ago - OmniAb to Report Fourth Quarter 2024 Financial Results on March 18 - Business Wire
- 7 weeks ago - OmniAb to Participate in Two Investor Conferences in March - Business Wire
- 2 months ago - Kuehn Law Encourages Investors of OmniAb, Inc. to Contact Law Firm - PRNewsWire
- 3 months ago - OmniAb Technologies Featured in Two Presentations at the 2024 Antibody Engineering & Therapeutics Conference - Business Wire
- 4 months ago - OmniAb, Inc. (OABI) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - OmniAb Reports Third Quarter 2024 Financial Results and Business Highlights - Business Wire